Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dymind is a China-based in vitro diagnostics and medical device company focused on the research, manufacture, sale, and service of diagnostic instruments and reagents. The company’s commercial portfolio spans hematology, coagulation, point-of-care testing, immunology, biochemistry, and veterinary diagnostics, with products marketed globally. Dymind emphasizes integrated laboratory solutions and has highlighted AI-enabled analyzers and digital detection solutions as part of its product strategy. The business appears to be fully commercial rather than a therapeutics developer, with revenues derived from diagnostic platforms, consumables, and associated services. For a biotech or healthcare analyst, Dymind is best understood as a private IVD diagnostics manufacturer with substantial international reach and strong positioning in hematology and adjacent routine testing segments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dymind.